troubles oculaires
Revue générale des uvéites
Références pour le traitement
1.Jaffe GJ, Dick AD, Brézin AP, et al: Adalimumab in patients with active noninfectious uveitis.N Engl J Med8;375(10):932-43, 2016. doi: 10.1056/NEJMoa1509852 2.Lee J, Koreishi AF, Zumpf KB, et al: Success of weekly adalimumab in refractory ocular inflammatory disease.OphthalmologyS0161-6420(20)30333-X, 2020. doi: 10.1016/j.ophtha.2020.04.009 3.Kruh JN, Yang P, Suelves AM, et al: Infliximab for the treatment of refractory noninfectious uveitis: A study of 88 patients with long-term follow-up.Ophthalmology121(1):358-364, 2014. doi: 10.1016/j.ophtha.2013.07.019 